1. Home
  2. ARTL vs CREV Comparison

ARTL vs CREV Comparison

Compare ARTL & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • CREV
  • Stock Information
  • Founded
  • ARTL 2011
  • CREV 2007
  • Country
  • ARTL United States
  • CREV Ireland
  • Employees
  • ARTL N/A
  • CREV N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • ARTL Health Care
  • CREV
  • Exchange
  • ARTL Nasdaq
  • CREV Nasdaq
  • Market Cap
  • ARTL 7.0M
  • CREV 6.0M
  • IPO Year
  • ARTL N/A
  • CREV N/A
  • Fundamental
  • Price
  • ARTL $5.47
  • CREV $4.10
  • Analyst Decision
  • ARTL Buy
  • CREV
  • Analyst Count
  • ARTL 2
  • CREV 0
  • Target Price
  • ARTL $30.00
  • CREV N/A
  • AVG Volume (30 Days)
  • ARTL 120.0K
  • CREV 32.6K
  • Earning Date
  • ARTL 11-11-2025
  • CREV 05-14-2025
  • Dividend Yield
  • ARTL N/A
  • CREV N/A
  • EPS Growth
  • ARTL N/A
  • CREV N/A
  • EPS
  • ARTL N/A
  • CREV N/A
  • Revenue
  • ARTL N/A
  • CREV $39,261,077.00
  • Revenue This Year
  • ARTL N/A
  • CREV $40.76
  • Revenue Next Year
  • ARTL N/A
  • CREV $86.18
  • P/E Ratio
  • ARTL N/A
  • CREV N/A
  • Revenue Growth
  • ARTL N/A
  • CREV 41.52
  • 52 Week Low
  • ARTL $4.20
  • CREV $2.00
  • 52 Week High
  • ARTL $28.60
  • CREV $12.75
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 33.32
  • CREV 51.03
  • Support Level
  • ARTL $4.60
  • CREV N/A
  • Resistance Level
  • ARTL $5.75
  • CREV $4.32
  • Average True Range (ATR)
  • ARTL 0.52
  • CREV 0.35
  • MACD
  • ARTL -0.07
  • CREV -0.17
  • Stochastic Oscillator
  • ARTL 24.52
  • CREV 81.68

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: